TARDBP and amyotrophic lateral sclerosis: Furthermore, 2–4% of ALS patients harbor mutations in TDP-43, which together with the presence of wild-type TDP-43 in pathological aggregates highlight its role as a common denominator for the majority of ALS cases and a significant fraction of related neurodegenerative disorders.